Researchers analyze 189 colorectal cancer tumors to study young-onset cases
A study of more than 850,000 cells may provide insights into why colorectal cancer is rising among younger people.

Researchers have published a study analyzing 189 colorectal cancer tumors from people aged 20 to 90, including 54 patients diagnosed before age 50. The team examined more than 850,000 cells to find clues that might lead to breakthroughs in prevention and treatments.
The study, published in Nature Medicine, was conducted by researchers from Dana-Farber Cancer Institute, Mass General Brigham, and the Broad Institute. Scientists observed that tumors in younger patients appeared to have a higher proportion of stromal cells, which are connective and supporting cells. Studies of other solid cancers have linked these cells to chemotherapy resistance.
Dr. Kimmie Ng, a senior author and director of the Young-Onset Colorectal Cancer Center at Dana-Farber, said the dataset is the largest to date for colorectal cancer and includes the highest number of young patients. The research also found differences in how genes are expressed in the tumors of younger people.
In the United States, colorectal cancer is the leading cause of cancer death among people younger than 50, with rates in that group rising nearly 3 percent each year from 2013 through 2022. While evidence has linked risk to diet and ultra-processed foods, experts say it is important to understand what is happening inside the tumors of younger patients.
Dr. John Paul Shen, an associate professor at the University of Texas MD Anderson Cancer Center, said the dataset allows for clear experiments in labs around the world. However, he and other experts noted that the dataset is drawn from a limited number of people.
Ana Anderson, a senior author from Brigham and Women’s Hospital, said the study provides a research direction to find therapies specifically for young-onset colon cancer. Dr. Christina Annunziata of the American Cancer Society said having the dataset is an essential first step to understanding why people are getting cancers early.
Key facts
- The study analyzed 189 tumors and more than 850,000 cells.
- Colorectal cancer rates in Americans under 50 rose nearly 3 percent annually from 2013 to 2022.
- Younger patients' tumors showed a higher proportion of stromal cells.
Three perspectives
Neutral
The study analyzed 189 colorectal cancer tumors from patients aged 20 to 90 to identify differences between younger and older patients.
Positive
The research provides a large dataset that may lead to tailored therapies for young-onset colon cancer.
Negative
Colorectal cancer is now the leading cause of cancer death for people younger than 50 in the United States.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.
